All feline diagnoses

Your cat was diagnosed with Oral Squamous Cell Carcinoma. Most common oral malignancy in cats. Extremely aggressive with very poor prognosis. MST untreated 44-60 days. <10% one-year survival with any treatment. Compare 5 treatment options for cats including Mandibulectomy / Maxillectomy, Radiation + Carboplatin (Concomitant), Toceranib (Palladia) — with survival times, costs, and what to expect during treatment.

🐈

Oral Squamous Cell Carcinoma

variable

feline

Epithelial

About This Cancer

Oral squamous cell carcinoma is the most common malignant tumour of the mouth in cats and carries an extremely poor prognosis. The cancer arises from the squamous epithelial cells lining the oral cavity, most frequently under the tongue (sublingual) or along the gums. It is aggressively invasive locally, rapidly destroying bone and soft tissue, and affected cats often present with drooling, difficulty eating, bloody oral discharge, or weight loss. Without treatment, survival is typically only one to two months. Unfortunately, even with aggressive treatment combinations (surgery, radiation, chemotherapy), long-term survival remains poor — fewer than 10% of cats survive one year. The cancer's resistance to treatment and the anatomical challenges of the feline mouth make this one of the most difficult cancers to manage in veterinary oncology.

WHO TNM Staging for Feline Oral Tumours

Based on tumour size, lymph node involvement, and distant metastasis. Adapted from canine oral tumour staging.

Stage T1Tumour <2 cm maximum diameter
Stage T2Tumour 2-4 cm maximum diameter
Stage T3Tumour >4 cm maximum diameter
Stage N0No regional lymph node metastasis
Stage N1Ipsilateral movable lymph node involvement
Stage N2Bilateral or contralateral lymph node involvement
Stage M0No distant metastasis
Stage M1Distant metastasis present
Prognostic Factors(3)
Tumour locationRostral (accessible) location carries better surgical prognosis than caudal/sublingual(Northrup et al., 2006)
Tumour sizeTumours <2cm have better outcomes with surgery
COX-2 expressionOnly 18% of feline oral SCCs show high COX-2 expression (much lower than canine), limiting NSAID therapeutic relevance
Minimum Workup(5 steps)
1CT of head and neck (extent assessment, mandibular/maxillary bone involvement)
2Biopsy with histopathology (incisional preferred)
3Thoracic radiographs (metastasis screening)
4CBC, chemistry panel
5Regional lymph node assessment (mandibular, retropharyngeal)

Median Survival Time Comparison

How long the average patient survives with each treatment

Bar opacity reflects evidence strength
Mandibulectomy / Maxillectomy
~7 mo (1–24)
Radiation + Carboplatin (Concomitant)
~5.4 mo
Toceranib (Palladia)
~4.1 mo
Palliative Radiation Therapy
~3.7 mo (2–5)
Comfort Care / Palliation
~1.5 mo (1–2)
Reading this page: MST (Median Survival Time) is how long the average patient survives with a given treatment. ORR (Overall Response Rate) is the percentage of patients whose tumour shrank or disappeared. CR = Complete Response (tumour gone); PR = Partial Response (tumour shrank). Hover over any abbreviation for a quick explanation.
Strength of Evidence

Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.

StrongLarge published studies with strong agreement among veterinary oncologists.
ModerateWidely used in clinical practice, but supported by smaller or retrospective studies.
IndirectEvidence comes from a different tumour type or species and has been applied here.
LimitedVery little published data is available for this specific treatment.

Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.